Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Myofibroblasts produce the fibrous scar in hepatic fibrosis. In the carbon tetrachloride (CCl(4)) model of liver fibrosis, quiescent hepatic stellate cells (HSC) are activated to become myofibroblasts. When the underlying etiological agent is removed, clinical and experimental fibrosis undergoes a remarkable regression with complete disappearance of these myofibroblasts. Although some myofibroblasts apoptose, it is unknown whether other myofibroblasts may revert to an inactive phenotype during regression of fibrosis. We elucidated the fate of HSCs/myofibroblasts during recovery from CCl(4)- and alcohol-induced liver fibrosis using Cre-LoxP-based genetic labeling of myofibroblasts. Here we demonstrate that half of the myofibroblasts escape apoptosis during regression of liver fibrosis, down-regulate fibrogenic genes, and acquire a phenotype similar to, but distinct from, quiescent HSCs in their ability to more rapidly reactivate into myofibroblasts in response to fibrogenic stimuli and strongly contribute to liver fibrosis. Inactivation of HSCs was associated with up-regulation of the anti-apoptotic genes Hspa1a/b, which participate in the survival of HSCs in culture and in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, restored RSPO3 expression during HSC deactivation52,53 or by therapeutic interventions might help to regain hepatocyte functions.”
From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [52]
In the citing paper
“Animal models reinforce the capacity of the injured liver to regress fibrosis and provide important platform for dissecting underlying mechanisms, although it should be noted that fibrosis in mice regresses incredibly rapidly, which may be in part attributed to the short duration of models (weeks to months in mice vs. years to decades in humans) and initiation of fibrosis at relatively young age (”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [262]
In the citing paper
“Fibroblast activation also involves increased activity of key glycolytic enzymes, such as hexokinase 2 and lactate dehydrogenase (LDH)47, which in turn increase cell proliferation47 and collagen synthesis48.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [47]
In the citing paper
“During enhanced glycolysis, increased amounts of pyruvate are converted to acetyl-CoA in the mitochondrial matrix47 before entering the citric acid cycle. This yields intermediate metabolites, such as succinate, which promote fibrosis49.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [47]
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Self-citationSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Self-citationBataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075 · cited 8×
“Myofibroblasts are aSMA collagen type I cells that are absent from the normal uninjured liver, rapidly emerge infibrotic liver to produce thefibrous scar, and completely disappear with regression of liver fibrosis (1, 2).”
BackgroundInfluentialThe role of matrix stiffness in regulating cell behavior†
Wells, R. G. (2008) · Hepatology · doi:10.1002/hep.22193 · Cited by 1,059
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Lee, K. S., Buck, M., Houglum, K., & Chojkier, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118304 · Cited by 539
Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses
Winau, F., Hegasy, G., Weiskirchen, R., Weber, S., Cassan, C., Sieling, P. A., Modlin, R. L., Liblau, R. S., Gressner, A. M., & Kaufmann, S. H. E. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.011 · Cited by 410
Lee, C. G., Cho, S. J., Kang, M. J., Chapoval, S. P., Lee, P. J., Noble, P. W., Yehualaeshet, T., Lu, B., Flavell, R. A., Milbrandt, J., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040104 · Cited by 369
Cited by
Items 501–600 of 889
Liu, L., Li, B., Zhang, Y., Nie, Y., Zhang, W., Chen, P., Huang, C., & Zhu, X. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101548 · Cited by 17
Li, W., Chen, J. Y., Sun, C., Sparks, R. P., Pantano, L., Rahman, R., Moran, S. P., Pondick, J. V., Kirchner, R., Wrobel, D., et al. (2022) · eLife · doi:10.7554/elife.74513 · Cited by 17
Isolation of primary human liver cells from normal and nonalcoholic steatohepatitis livers
Liu, X., Lam, K., Zhao, H., Sakane, S., Kim, H. Y., Eguileor, Á., Diggle, K., Wu, S., Weber, R. C. G., Soroosh, P., et al. (2023) · STAR Protocols · doi:10.1016/j.xpro.2023.102391 · Cited by 17
Self-citationCrosstalk in extrahepatic and hepatic system in NAFLD / NASH
Duan, Y., Yang, Y. Z., Zhao, S., Bai, Y., Yao, W., Gao, X., & Yin, J. (2024) · Liver International · doi:10.1111/liv.15967 · Cited by 17
Kang, L., Isse, K., Koral, K., Bowen, W. C., Muratoglu, S. C., Strickland, D. K., Michalopoulos, G. K., & Mars, W. M. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.94 · Cited by 17
Zhang, H., Wu, P., Chen, F., Hao, Y., Lao, Y., Ren, L., Sun, L., Sun, W., Wei, H., Chan, D. W., et al. (2014) · PROTEOMICS · doi:10.1002/pmic.201300539 · Cited by 17
Effect of histone deacetylase inhibitor on epithelial‐mesenchymal transition of liver fibrosis
Ramzy, M. M., Abdelghany, H. M., Zenhom, N. M., & El‐Tahawy, N. F. G. (2018) · IUBMB Life · doi:10.1002/iub.1742 · Cited by 17
Sharma, S. K., Ghufran, S. M., Das, B., Roy, B., Ghose, S., & Biswas, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120119 · Cited by 17
Salama, Y., Hassan, H. M., El-Gayar, A. M., & Abdel‐Rahman, N. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122349 · Cited by 17
The Mechanisms of HSC Activation and Epigenetic Regulation of HSCs Phenotypes
Page, A., Mann, D. A., & Mann, J. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0052-0 · Cited by 17
Stone, L. C., Thorne, L. S., Weston, C. J., Graham, M., & Hodges, N. J. (2015) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-015-0032-y · Cited by 17
Laminin-521 promotes quiescence in isolated stellate cells from rat liver
Rohn, F., Kordes, C., Castoldi, M., Götze, S., Poschmann, G., Stühler, K., Herebıan, D., Benk, A. S., Geiger, F., Zhang, T., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.008 · Cited by 17
Huang, X., Wang, L., Meng, M., Zhang, S., Pham, T. T. H., Jiang, L., Chen, L., Li, Y., Zhou, X., Qin, L., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109516 · Cited by 17
Mendoza, Y. P., Tsouka, S., Semmler, G., Seubnooch, P., Freiburghaus, K., Mandorfer, M., Bosch, J., Masoodi, M., & Berzigotti, A. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.06.028 · Cited by 16
Liu, X., Zhang, W., Ma, B.-F., Sun, M., & Shang, Q.-H. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s467480 · Cited by 16
Siling, B., Chu, F., Wang, M., Bi, L., Mao, P., Zhang, H., Wang, P., Guo, W., Xu, L., Ren, L., et al. (2016) · Molecules · doi:10.3390/molecules21111599 · Cited by 16
Loss of pericyte smoothened activity in mice with genetic deficiency of leptin
Xie, G., Swiderska‐Syn, M., Jewell, M. L., Machado, M. V., Michelotti, G. A., Premont, R. T., & Diehl, A. M. (2017) · BMC Cell Biology · doi:10.1186/s12860-017-0135-y · Cited by 16
Lai, S., Fu, X., Cheng, Q., Yu, Z., Jiang, E., Zhao, D., Yu, D., Qiu, Y., Gao, X., Ju, H., et al. (2019) · PubMed · Cited by 16
Walter, S. G., Scheidt, S., Nißler, R., Gaisendrees, C., Zarghooni, K., & Schildberg, F. A. (2021) · Cancers · doi:10.3390/cancers13061466 · Cited by 16
Mineralocorticoid receptors in non‐alcoholic fatty liver disease
Schreier, B., Zipprich, A., Uhlenhaut, N. H., & Gekle, M. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15784 · Cited by 16
Bai, L., Wang, Y., Chen, Y., Li, H., Zhu, S., Liu, Y., Song, Z., & Duan, S. (2022) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13682 · Cited by 16
Wu, X., Liu, X., Liu, Z., Xia, G., Zhu, H., Zhang, M.-D., Wu, B., & Lv, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109229 · Cited by 16
RNA Binding Proteins Control Transdifferentiation of Hepatic Stellate Cells into Myofibroblasts
Wang, S., Jung, Y., Hyun, J., Friedersdorf, M. B., Oh, S., Kim, J., Premont, R. T., Keene, J. D., & Diehl, A. M. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491987 · Cited by 16
Future mechanistic strategies for tackling fibrosis–an unmet need in liver disease
Fallowfield, J. A. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-6-s83 · Cited by 15
Azizsoltani, A., Niknam, B., Taghizadeh-Teymorloei, M., Ghoodjani, E., Dianat-Moghadam, H., & Alizadeh, E. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118249 · Cited by 15
Lee, H., Mun, S. J., Jung, C., Kang, H., Kwon, J., Ryu, J., Ahn, H., Kwon, O., Ahn, J., Moon, K.-S., et al. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28333 · Cited by 15
Hansen, J. K., Israelsen, M. E., Nishijima, S., Stinson, S. E., Andersen, P., Johansen, S., Hansen, C. D., Brol, M. J., Klein, S., Schierwagen, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60755-9 · Cited by 15
COOK, D. J., Achanta, S., Hoek, J. B., Ogunnaike, B. A., & Vadigepalli, R. (2018) · BMC Systems Biology · doi:10.1186/s12918-018-0605-7 · Cited by 15
Nanomedicine for Hepatic Fibrosis
Ezhilarasan, D., & Rajeshkumar, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-0391-7_2 · Cited by 15
Extracellular Vesicles from Stem and Progenitor Cells for Cell-Free Regenerative Therapy
Haque, N., Widera, D., Govindasamy, V., Soesilawati, P., & Kasim, N. H. A. (2021) · Current Molecular Medicine · doi:10.2174/1566524021666210125114828 · Cited by 15
Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37
Borrello, M. T., & Mann, D. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15853 · Cited by 15
Ly, T.-D., Sambale, M., Klösener, L., Traut, P., Fischer, B., Hendig, D., Kühn, J., Knabbe, C., & Faust, I. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286334 · Cited by 15
Yang, C., Geng, X., Wan, G., Song, L., Wang, Y., Zhou, G., Wang, J., & Pan, Z. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117720 · Cited by 15
Non-invasive PET imaging of liver fibrogenesis using a RESCA-conjugated Affibody molecule
Wegrzyniak, O., Lechi, F., Mitran, B., Cheung, P., Bitzios, A., Persson, J., Löfblom, J., Nordström, H., Eriksson, J., Frejd, F. Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109688 · Cited by 14
Валерьевна, К. И., Topchieva, L., Дуданова, О. П., & Shipovskaya, A. A. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924110130 · Cited by 14
Kim, J., Lee, C., Noh, S. G., Kim, S., Chung, H. Y., Lee, H., & Moon, J. (2023) · Antioxidants · doi:10.3390/antiox12081588 · Cited by 14
Kim, E., Kim, H. K., Sul, J. H., Lee, J., Baek, S. H., Cho, Y., Han, J., Kim, J., Park, S., Park, J. H., et al. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.191 · Cited by 14
Liu, T., Li, H., Li, Y., Wang, L., Chen, G., Pu, G., Guo, X., Cho, W. C. S., Harandi, M. F., Zheng, Y., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.798551 · Cited by 14
Constrictive Bronchiolitis in Cystic Fibrosis Adolescents with Refractory Pulmonary Decline
Harris, W. T., Boyd, J. T., McPhail, G. L., Brody, A. S., Szczesniak, R. D., Korbee, L. L., Baker, M. L., & Clancy, J. P. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201412-594oc · Cited by 14
Tao, H., Liu, Q., Zeng, A., & Song, L. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110497 · Cited by 13
GL-V9 ameliorates liver fibrosis by inhibiting TGF-β/smad pathway
Guo, Y., Geng, T., Chen, X., Hou, Y., Zhang, X., Xue, X., Zhao, L., & Wu, Y. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113521 · Cited by 13
Han, X., Ning, Y., Dou, X., Wang, Y., Shan, Q., Shi, K., Wang, Z., Ding, C., Hao, M., Wang, K., et al. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.12.017 · Cited by 13
Conserved long noncoding RNA TILAM promotes liver fibrosis through interaction with PML in HSCs
Sun, C., Zhou, C., Daneshvar, K., Saad, A. B., Kratkiewicz, A. J., Toles, B. J., Arghiani, N., Hess, A., Chen, J. Y., Pondick, J. V., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000822 · Cited by 13
Hepatic perivascular mesenchymal stem cells with myogenic properties
Sudheer Shenoy, P., & Bose, B. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2503 · Cited by 13
The Wilms’ tumor suppressor gene regulates pancreas homeostasis and repair
Ariza, L., Rojas, A., Muñoz‐Chápuli, R., & Carmona, R. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1007971 · Cited by 13
Antifibrotic effects of total or partial application of amniotic membrane in hepatic fibrosis
MAMEDE, K. M., & Sant’Anna, L. B. (2019) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201920190220 · Cited by 13
You, H., Wang, L., Bu, F., Meng, H., Pan, X., Li, J., Zhang, Y., Wang, A., Yin, N., Huang, C. Z., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002319rrr · Cited by 13
Fibrogénesis hepática: fisiopatología
Òdena, G., & Bataller, R. A. (2012) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(12)70043-2 · Cited by 13
New Approaches for Studying Alcoholic Liver Disease
Xu, J., Liu, X., Gao, B., Karin, M., Tsukamoto, H., Brenner, D. A., & Kisseleva, T. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0053-z · Cited by 13
Self-citationRegulatory Effects and Mechanism of Adenovirus-Mediated PTEN Gene on Hepatic Stellate Cells
An, J., Zheng, L., Xie, S., Yin, F., Huo, X., Guo, J., & Zhang, X. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3976-2 · Cited by 13
Jing, F., Geng, Y., Xu, X., Xu, H., Shi, J., & Xu, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040796 · Cited by 13
Jia, H., Ding, L., Yu, A., Tang, W., Tang, S., Zhang, C., & Oupický, D. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.07.018 · Cited by 12
Protozoan‐Derived Cytokine‐Transgenic Macrophages Reverse Hepatic Fibrosis
Chen, Y., Wang, J., Zhou, N., Fang, Q., Cai, H., Du, Z., An, R., Liu, D., Chen, X., Wang, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202308750 · Cited by 12
Kandhi, R., Yeganeh, M., Yoshimura, A., Menéndez, A., Ramanathan, S., & Ilangumaran, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1259246 · Cited by 12
Wu, H., Wu, L., Xiao, L., Gu, Y., Liu, H., Zhang, L., Zhang, M., & Qi, L. (2023) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13753 · Cited by 12
Su, X., Zhong, H., Zeng, Y., Zhang, Y., Zhang, B., Guo, W., Huang, Q., & Ye, Y. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114376 · Cited by 12
Relationship of and cross-talk between physical and biologic properties of the glomerulus
Miller, R. T., & Janmey, P. A. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000138 · Cited by 12
Critical Role of Cysteine-Rich Protein 61 in Mediating the Activation of Renal Fibroblasts
Liu, H., Zhao, L., Zhang, J., Li, C., Shen, X., Liu, X., Jiang, W., Luo, C., Wang, Y., Che, L., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00464 · Cited by 12
The Effect of Splenectomy on the Reversal of Cirrhosis: a Prospective Study
Zeng, D., Liang, D., Zhang, R.-C., Guo, Q., Duan, B., Jia, C., Chen, F., Lin, D., Zang, Y., & Lu, S. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/5459427 · Cited by 12
El-Maadawy, W. H., el-Din, S. H. S., Ezzat, S. M., Hammam, O. A., Safar, M. M., Saleh, S., & El-Lakkany, N. M. (2021) · Journal of Herbs Spices & Medicinal Plants · doi:10.1080/10496475.2021.1911905 · Cited by 12
Li, J., Zhang, L., Xia, Q., Fu, J., Zhou, Z., & Lin, F. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.164 · Cited by 12
Nataraj, K., Schonfeld, M. P., Rodriguez, A., Sharma, M., Weinman, S. A., & Tikhanovich, I. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101414 · Cited by 12
The cellular microenvironment and cytoskeletal actin dynamics in liver fibrogenesis
Hijazi, N., Rockey, D. C., & Shi, Z. (2022) · Biocell · doi:10.32604/biocell.2022.020171 · Cited by 11
Xu, Y. Y., Liu, F., He, D., Han, L., Zheng, X., Hu, M., & Chen, P. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152315 · Cited by 11
Bromodomain protein 4 is a key molecular driver of TGFβ1-induced hepatic stellate cell activation
Xu, F., Lu, S., Pan, N., Zhao, F., Jia, X., Wang, S., Zhang, Y., & Zhou, Y. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119569 · Cited by 11
ADAMTS12 is a stromal modulator in chronic liver disease
Dekky, B., Azar, F., Bonnier, D., Monseur, C., Kalebić, C., Arpigny, E., Colige, A., Legagneux, V., & Théret, N. (2023) · The FASEB Journal · doi:10.1096/fj.202200692rrrr · Cited by 11
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Joung, C., Heo, J., Pahk, K. J., & Pahk, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-66078-x · Cited by 11
Morphogen-related therapeutic targets for liver fibrosis
Fung, E., & Tsukamoto, H. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.05.017 · Cited by 11
Self-citationBenítez, R., Caro, M., Andrés‐León, E., O’Valle, F., & Delgado, M. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15752 · Cited by 11
Jung, H., Kyun, M.-L., Kwon, J.-I., Kim, J., Kim, J.-K., Park, D., Lee, Y. B., & Moon, K.-S. (2024) · Biomaterials Science · doi:10.1039/d4bm00874j · Cited by 10
Mittal, A., Choudhary, N., Chaudhary, S., Kumari, A., Rastogi, A., Kumar, G., Maras, J. S., Sarin, S. K., & Sharma, S. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101565 · Cited by 10
Zhong, H., Liu, C., Huang, Z., Tan, P., Chen, H., & Fu, W. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.02.003 · Cited by 10
Toya, K., Tomimaru, Y., Kobayashi, S., Harada, A., Sasaki, K., Iwagami, Y., Yamada, D., Noda, T., Takahashi, H., Kado, T., et al. (2023) · Transplantation · doi:10.1097/tp.0000000000004567 · Cited by 10
Dai, X., Zheng, H.-L., Ma, Y.-X., Wang, Y., Wang, M.-Q., Cai, H., Hu, Z., Wan, J., & Zhang, L. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2902062 · Cited by 10
Nakano, Y., Saijou, E., Itoh, T., Tanaka, M., Miyajima, A., & Kido, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-58989-6 · Cited by 10
Xu, C., Tai, H., Chu, Y., Liu, Y., He, J., Wang, Y., Su, B., & Li, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1385330 · Cited by 10
Senescent lung-resident mesenchymal stem cells drive pulmonary fibrogenesis through FGF-4/FOXM1 axis
Liu, Y., Ji, J., Zheng, S., Wei, A., Li, D., Shi, B., Han, X., & Chen, X. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03866-2 · Cited by 10
Lim, Y. W., Quinn, R., Bharti, K., Ferrer, M., Zarkoob, H., & Song, M. J. (2024) · Biofabrication · doi:10.1088/1758-5090/ad998c · Cited by 11
Ning, M., Lu, D., Liang, D., & Ren, P. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1513993 · Cited by 11
Guido, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-42873-6.00040-8 · Cited by 10
Kosinski, A. M., Sivasankar, M. P., & Panitch, A. (2015) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35456 · Cited by 10
van Dijk, F., Hazelhoff, C. M., Post, E., Prins, G. H., Rombouts, K., Poelstra, K., Olinga, P., & Beljaars, L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030278 · Cited by 10
Novel mouse model for cholestasis‐induced liver fibrosis resolution by cholecystojejunostomy
Yoshino, K., Taura, K., Iwaisako, K., Masano, Y., Uemoto, Y., Kimura, Y., Nam, N. H., Nishino, H., Ikeno, Y., Okuda, Y., et al. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15406 · Cited by 9
Self-citationThe Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
Nishio, T., Koyama, Y., Fuji, H., Ishizuka, K., Iwaisako, K., Taura, K., Hatano, E., Brenner, D. A., & Kisseleva, T. (2022) · Biology · doi:10.3390/biology11111589 · Cited by 13
Self-citationSharma, S. K., Ghufran, S. M., Aftab, M., Bihari, C., Ghose, S., & Biswas, S. (2024) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.12015 · Cited by 9
Pharmacological manipulation of liver fibrosis progression using novel HDAC 6 inhibitors
Borrello, M. T., Ružić, D., Paish, H. L., Graham, E., Collins, A., Scott, R., Higginbotham, S., Radović, B., Nelson, G., Bulmer, D. M., et al. (2025) · FEBS Journal · doi:10.1111/febs.70062 · Cited by 9
Grant, M. P., Henley, N., Dubuissez, M., Chen, N., Hartmann, U., Royal, V., Barbier, O. C., Pichette, V., & Gerarduzzi, C. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00277.2021 · Cited by 9
Sarkar, A., Das, S., Bone, H., DeVengencie, I., Prasad, J. M. N., Farkas, D., Londino, J. D., Nho, R. S., Rojas, M. M., & Horowitz, J. C. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200511 · Cited by 9
Stellate Cells, Portal Myofibroblasts, and Epithelial-to-Mesenchymal Transition
Koyama, Y., Wang, P., Brenner, D. A., & Kisseleva, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00006-3 · Cited by 9
Self-citationWang, M., Chien, C., Yu, H., Wang, P., & Lin, W. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00326 · Cited by 9
Role of mitogens in normal and pathological liver regeneration
Vosough, M., Shokouhian, B., Sharbaf, M. A., Solhi, R., Heidari, Z., Seydi, H., Hassan, M., Ezhilarasan, D., & Najimi, M. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000692 · Cited by 9
RUNX1 is a mediator of fibrotic activation and epigenetic memory in lung fibroblasts
Gilbert, R. M., Jones, D. L., Wellmerling, J. H., Caporarello, N., Meridew, J. A., Choi, K., Haak, A. J., Link, P. A., Tan, Q., Lee, J., et al. (2026) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1093/ajrcmb/aanag022 · Cited by 8
Loss of heat shock factor 1 promotes hepatic stellate cell activation and drives liver fibrosis
Choudhury, A., Ratna, A., Lim, A., Sebastian, R. M., Moore, C. L., Filliol, A. A., Bledsoe, J. R., Dai, C., Schwabe, R. F., Shoulders, M. D., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.2058 · Cited by 8
Yamaguchi, M., Kanazawa, T., Morino, S., Iioka, S., Watanabe, Y., Dohi, N., Higashi, K., Kondo, H., & Ishikawa, T. (2022) · Membranes · doi:10.3390/membranes12101023 · Cited by 8
Design, synthesis and anti-hepatic fibrosis activity of novel diphenyl vitamin D receptor agonists
Xing, K., Wu, Y., Gao, F., Dai, Y., Guan, C., Tong, Y., Gao, Y., Wang, C., & Zhang, C. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115596 · Cited by 8
Liver fibrosis pathologies and potentials of RNA based therapeutics modalities
Diwan, R., Gaytan, S. L., Bhatt, H. N., Pena‐Zacarias, J., & Nurunnabi, M. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01551-8 · Cited by 8
Graphene Quantum Dots Reduce Hypertrophic Scar by Inducing Myofibroblasts To Be a Quiescent State
Huang, H., Liu, W., Lin, J., Shu, F., Xia, Z., & Zheng, Y. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c05731 · Cited by 8
Purinergic Signaling in Non-Parenchymal Liver Cells
Martínez, E. M., Ramírez‐Ledesma, M. G., Vázquez‐Victorio, G., Hernández-Muñoz, R. E., Díaz‐Muñoz, M., & Vázquez‐Cuevas, F. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179447 · Cited by 8
Sirosis Hepatis - Reversibel atau Irreversibel?
Yong, B. J. C., & Vidor, M. (2022) · Cermin Dunia Kedokteran · doi:10.55175/cdk.v49i1.1644 · Cited by 8
Chen, N., Liu, S., Qin, D., Guan, D., Chen, Y., Hou, C., Zheng, S., Wang, L., Chen, X., Chen, W., et al. (2023) · Cell Proliferation · doi:10.1111/cpr.13500 · Cited by 8
Metadata
- Authors
- Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., Evans, S. M., Dillmann, W., Glass, C. K., & Brenner, D. A.
- Affiliations
- Department of Medicine,
- Universitätsklinikum Aachen (DE)
- Department of Cellular and Molecular Medicine,
- School of Pharmacy, University of California, San Diego, CA 92093;
- University of Southern California (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-05-07
- Volume
- 109
- Issue
- 24
- Pages
- 9448-9453
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3386114
- OpenAlex
- W2075290880
- Cited by
- 805
- References
- 27
- Citations by year
- 2026: 29 · 2025: 51 · 2024: 61 · 2023: 59 · 2022: 53 · 2021: 62 · 2020: 64 · 2019: 52 · 2018: 53 · 2017: 61 · 2016: 64 · 2015: 73 · 2014: 63 · 2013: 42 · 2012: 13
- FWCI
- 38.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM041804)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- myofibroblasts, hepatic stellate cells, liver fibrosis, fibrosis regression, apoptosis, anti-apoptotic genes, carbon tetrachloride, alcohol-induced liver injury, fibrogenic gene expression
- MeSH terms
- Animals, Liver Cirrhosis, Phenotype, Tamoxifen, Adoptive Transfer, Collagen Type I, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.